Literature DB >> 25944330

Endovascular clot retrieval therapy: implications for the organization of stroke systems of care in North America.

Eric E Smith1, Lee H Schwamm2.   

Abstract

Endovascular acute ischemic stroke therapy is now proven by randomized controlled trials to produce large, clinically meaningful benefits. In response, stroke systems of care must change to increase timely and equitable access to this therapy. In this review, we provide a North American perspective on implications for stroke systems, focusing on the United States and Canada, accompanied by initial recommendations for changes. Most urgently, every community must create access to a hospital that can safely and quickly provide intravenous tissue-type plasminogen activator and immediately transfer appropriate patients onward to a more capable center as required. Safe and effective therapy in the community setting will be ensured by certification programs, performance measurement, and data entry into registries.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  quality improvement; stroke

Mesh:

Substances:

Year:  2015        PMID: 25944330     DOI: 10.1161/STROKEAHA.115.008385

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  16 in total

1.  Estimated Impact of Emergency Medical Service Triage of Stroke Patients on Comprehensive Stroke Centers: An Urban Population-Based Study.

Authors:  Brian S Katz; Opeolu Adeoye; Heidi Sucharew; Joseph P Broderick; Jason McMullan; Pooja Khatri; Michael Widener; Kathleen S Alwell; Charles J Moomaw; Brett M Kissela; Matthew L Flaherty; Daniel Woo; Simona Ferioli; Jason Mackey; Sharyl Martini; Felipe De Los Rios la Rosa; Dawn O Kleindorfer
Journal:  Stroke       Date:  2017-07-12       Impact factor: 7.914

2.  Stroke Treatment Academic Industry Roundtable: The Next Generation of Endovascular Trials.

Authors:  Tudor G Jovin; Gregory W Albers; David S Liebeskind
Journal:  Stroke       Date:  2016-09-01       Impact factor: 7.914

3.  Availability of endovascular therapies for cerebrovascular disease at primary stroke centers.

Authors:  Mark J Alberts; Jean Range; William Spencer; Vicki Cantwell; M J Hampel
Journal:  Interv Neuroradiol       Date:  2016-11-30       Impact factor: 1.610

Review 4.  Telestroke.

Authors:  Oana M Dumitrascu; Bart M Demaerschalk
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

Review 5.  A Network Approach to Stroke Systems of Care.

Authors:  Kori S Zachrison; Amar Dhand; Lee H Schwamm; Jukka-Pekka Onnela
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-08-13

Review 6.  Current Endovascular Approach to the Management of Acute Ischemic Stroke.

Authors:  Rakesh Khatri; Anantha R Vellipuram; Alberto Maud; Salvador Cruz-Flores; Gustavo J Rodriguez
Journal:  Curr Cardiol Rep       Date:  2018-05-07       Impact factor: 2.931

Review 7.  Thrombectomy for Acute Ischemic Stroke: Recent Insights and Future Directions.

Authors:  Aravind Ganesh; Mayank Goyal
Journal:  Curr Neurol Neurosci Rep       Date:  2018-07-23       Impact factor: 5.081

8.  Definition and Implications of the Preventable Stroke.

Authors:  Mark Fisher; Lisa Moores; Mohamad N Alsharif; Annlia Paganini-Hill
Journal:  JAMA Neurol       Date:  2016-02       Impact factor: 18.302

9.  Clinical Imaging Factors Associated With Infarct Progression in Patients With Ischemic Stroke During Transfer for Mechanical Thrombectomy.

Authors:  Gregoire Boulouis; Arne Lauer; Ahmer Khawdja Siddiqui; Andreas Charidimou; Robert W Regenhardt; Anand Viswanathan; Natalia Rost; Thabele M Leslie-Mazwi; Lee H Schwamm
Journal:  JAMA Neurol       Date:  2017-11-01       Impact factor: 18.302

10.  Delays in the Air or Ground Transfer of Patients for Endovascular Thrombectomy.

Authors:  Robert W Regenhardt; Adam P Mecca; Stephanie A Flavin; Gregoire Boulouis; Arne Lauer; Kori Sauser Zachrison; James Boomhower; Aman B Patel; Joshua A Hirsch; Lee H Schwamm; Thabele M Leslie-Mazwi
Journal:  Stroke       Date:  2018-04-30       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.